The Patent Finder

Methods for Treating Chronic Obstructive Pulmonary Disease

Theravance, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 62/724,805, filed Aug 30, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,048,692Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · Medium confidence
Theravance Biopharma R&D IP, LLCIn force
Medium confidence
US 12,285,417Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · Medium confidence
Theravance Biopharma R&D IP, LLCIn force
Medium confidence
US 11,484,531Methods for Treating Chronic Obstructive Pulmonary Disease
In force
 · High confidence
Theravance Biopharma R&D IP, LLCIn force
High confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited